Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New developments in cardiac surgery.

Francis Wellens1, Jacques Goldstein,

  • 1Cardiovasculaire en Thoracale Heelkunde, Moorselbaan 164, B-9300 Aalst, Belgium. francis.wellens@olvz-aalst.be

Acta Cardiologica
|August 5, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A prospective clinical evaluation of new ECCO2R technology in mild to moderate ARDS patients: assessing ultra-lung-protective ventilation with PRISMALUNG.

Critical care (London, England)·2026
Same author

Implantable Cardioverter-Defibrillator Therapy in Brugada Syndrome: A 30-Year Single-Center Experience.

JACC. Clinical electrophysiology·2025
Same author

A chart review on surgical myocardial debridging in symptomatic patients: a safe procedure with good long-term clinical outcome and coronary computed tomographic angiography results.

Interdisciplinary cardiovascular and thoracic surgery·2023
Same author

Adsorptive hemofiltration for sepsis management: expert recommendations based on the Asia Pacific experience.

Chinese medical journal·2021
Same author

A preliminary cost-effectiveness analysis of lung protective ventilation with extra corporeal carbon dioxide removal (ECCO<sub>2</sub>R) in the management of acute respiratory distress syndrome (ARDS).

Journal of critical care·2021
Same author

ECCO<sub>2</sub>R therapy in the ICU: consensus of a European round table meeting.

Critical care (London, England)·2020

Minimally invasive cardiac surgery, including endoscopic CABG and percutaneous valve procedures, is advancing rapidly. However, high financial costs necessitate healthcare discussions to ensure future surgical care quality.

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Cardiac Surgery
  • Cardiac Valve Surgery
  • Heart Failure Therapy

Background:

  • Cardiac surgery is evolving towards less invasive approaches.
  • New devices and techniques are emerging for coronary artery bypass grafting (CABG) and valve replacement/repair.
  • Advancements in tissue engineering and heart failure treatments are also significant.

Purpose of the Study:

  • To review recent advancements in cardiac surgery, focusing on minimally invasive techniques.
  • To highlight innovations in CABG, valve surgery, and heart failure therapy.
  • To address the financial implications of these surgical developments.

Main Methods:

  • Review of current clinical practices and emerging technologies in cardiac surgery.

Related Experiment Videos

  • Analysis of new anastomotic devices for endoscopic CABG.
  • Assessment of percutaneous techniques for aortic valve replacement (AVR), pulmonary valve replacement (PVR), and mitral valve repair.
  • Consideration of tissue engineering for heart valves and new heart failure therapies.

    • Main Results:

    • Clinically available anastomotic devices facilitate endoscopic CABG.
    • Percutaneous techniques are established for AVR and PVR, with mitral valve repair progressing.
    • Tissue engineering promises biocompatible heart valves.
    • Significant progress is noted in heart failure treatment development.

    Conclusions:

    • Minimally invasive techniques are transforming cardiac surgery.
    • The high financial cost of these advancements is a major concern.
    • An open dialogue among healthcare stakeholders is crucial to maintain surgical care quality.